L-AP6

Discontinued Product

0341 has been discontinued.

View all Miscellaneous Glutamate products.
Description: Selective agonist of the 'quis' effect
Chemical Name: L-(+)-2-Amino-6-phosphonohexanoic acid
Datasheet
Citations
Reviews
Literature (3)

Biological Activity for L-AP6

L-AP6 is a selective agonist for 'quis'-sensitized site.

Technical Data for L-AP6

M. Wt 211.15
Formula C6H14NO5P
Storage Store at RT
CAS Number 78944-89-5
PubChem ID 3062646
InChI Key QIOXWRQXHFVNLV-YFKPBYRVSA-N
Smiles [H][C@@](CCCCP(O)(O)=O)(N)C(O)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Keywords: L-AP6, L-AP6 supplier, Selective, agonists, quis, effect, Glutamate, mGlur, Receptors, Metabotropic, iGluR, Ionotropic, Miscellaneous, 0341, Tocris Bioscience

Citations for L-AP6

Citations are publications that use Tocris products.

Currently there are no citations for L-AP6.

Reviews for L-AP6

There are currently no reviews for this product. Be the first to review L-AP6 and earn rewards!

Have you used L-AP6?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Metabotropic Glutamate Receptors Scientific Review

Metabotropic Glutamate Receptors Scientific Review

Written by Francine Acher, this review discusses the pharmacology and therapeutic potential of mGlu receptors, and the compounds acting upon them; compounds available from Tocris are listed.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.